Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
14.04
-1.26 (-8.24%)
At close: Feb 20, 2026, 4:00 PM EST
14.41
+0.37 (2.64%)
After-hours: Feb 20, 2026, 7:51 PM EST
TNXP Market Cap
TNXP has a market cap or net worth of $179.63 million as of February 20, 2026. Its market cap has increased by 114.49% in one year.
Market Cap
179.63M
Enterprise Value
-10.00M
1-Year Change
114.49%
Ranking
Category
Stock Price
$14.04
Market Cap Chart
Since July 16, 2019, TNXP's market cap has increased from $7.29M to $179.63M, an increase of 2,362.78%. That is a compound annual growth rate of 62.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 179.63M | -7.20% |
| Dec 31, 2025 | 193.56M | 214.02% |
| Dec 31, 2024 | 61.64M | 160.94% |
| Dec 29, 2023 | 23.62M | 5.35% |
| Dec 30, 2022 | 22.42M | -87.36% |
| Dec 31, 2021 | 177.42M | 37.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ovid Therapeutics | 191.37M |
| Kalaris Therapeutics | 187.02M |
| Canton Strategic Holdings | 185.00M |
| Cartesian Therapeutics | 180.20M |
| Molecular Partners AG | 178.48M |
| Karyopharm Therapeutics | 177.39M |
| Editas Medicine | 174.74M |
| Eledon Pharmaceuticals | 173.78M |